Affect Therapeutics
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $44M
Investors
- 8
About Affect Therapeutics
a. Affect Therapeutics operates as a developer of a healthtech software platform that provides digital solutions for people with alcohol and drug addiction. In November 2025, Affect Therapeutics, Inc. The company provides a smartphone application that reimagines drug and alcohol addiction treatment via an integrated treatment program. The application offers an integrated all-digital addiction recovery program that offers professional support and financial rewards as individuals succeed in treatment.
Who invested in Affect Therapeutics
8 investors across 2 rounds
See all investors in Affect Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Affect Therapeutics
Who invested in Affect Therapeutics?
Affect Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Affect Therapeutics raised?
Affect Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Affect Therapeutics last raise money?
Affect Therapeutics's most recent round on record is a Series B, in Nov 2025.
What does Affect Therapeutics do?
Affect Therapeutics is a healthcare it company.
Where is Affect Therapeutics headquartered?
Affect Therapeutics is headquartered in McLean, US.
Which VCs invest in companies like Affect Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Affect Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Affect Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.